16 JUL 2018

UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the third quarter to 30 June 2018 at 7.00am (BST) on Wednesday 8 August 2018.


The Company will also host a conference call for investors and analysts at 9:00am (BST) on Wednesday 8 August 2018 to discuss the statement. The dial-in details are as follows:


International Access  +44 (0) 203 936 1888

UK Local Access  0203 936 1888

Ireland Local Access  0155 30187

USA Local Access  16469680351

Room number   985391

Participant PIN  8469


A playback facility will be available for seven days on 0203 936 1888. The access code for the replay will be 517509.

For further information, please contact:

Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000

Lisa Kavanagh / Jana Tsiligiannis


Tel: +44-207-250-1446

Email: udghealthcare@powerscourt-group.com



UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing 9,000 people with operations in 25 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across three divisions: Ashfield, Sharp and Aquilant.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries.

It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of-the-art facilities in the US and Europe.

Aquilant is a leading provider of outsourced sales, marketing, engineering and distribution services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com